{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:47:24Z","timestamp":1790768844685,"version":"4.1.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European Research Council","award":["Starting Grant"],"award-info":[{"award-number":["Starting Grant"]}]},{"DOI":"10.13039\/100005932","name":"Center for Alternatives to Animal Testing, Johns Hopkins Bloomberg School of Public Health","doi-asserted-by":"publisher","award":["Project Grant"],"award-info":[{"award-number":["Project Grant"]}],"id":[{"id":"10.13039\/100005932","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fund for Scientific Research-Flanders","award":["Project Grant"],"award-info":[{"award-number":["Project Grant"]}]},{"name":"Willy Gepts Fonds UZ-Brussels","award":["Project Grant"],"award-info":[{"award-number":["Project Grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00204-019-02437-2","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T20:28:28Z","timestamp":1554928108000},"page":"1169-1186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Mechanisms and in vitro models of drug-induced cholestasis"],"prefix":"10.1007","volume":"93","author":[{"given":"Eva","family":"Gijbels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"Vilas-Boas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Deferm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Devisscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Jaeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vinken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"key":"2437_CR1","doi-asserted-by":"publisher","first-page":"e2390","DOI":"10.1038\/cddis.2016.280","volume":"7","author":"MB Afonso","year":"2016","unstructured":"Afonso MB, Rodrigues PM, Simao AL et al (2016) Activation of necroptosis in human and experimental cholestasis. Cell Death Dis 7:e2390","journal-title":"Cell Death Dis"},{"key":"2437_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1021\/acs.chemrestox.7b00048","volume":"30","author":"MD Aleo","year":"2017","unstructured":"Aleo MD, Shah F, He K et al (2017) Evaluating the role of multidrug resistance protein 3 (MDR3) inhibition in predicting drug-induced liver injury using 125 pharmaceuticals. Chem Res Toxicol 30:1219\u20131229","journal-title":"Chem Res Toxicol"},{"key":"2437_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejps.2017.02.011","volume":"103","author":"I Ali","year":"2017","unstructured":"Ali I, Welch MA, Lu Y et al (2017) Identification of novel MRP3 inhibitors based on computational models and validation using an in vitro membrane vesicle assay. Eur J Pharm Sci 103:52\u201359","journal-title":"Eur J Pharm Sci"},{"key":"2437_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.taap.2009.11.013","volume":"243","author":"K Allen","year":"2010","unstructured":"Allen K, Kim ND, Moon JO et al (2010) Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol 243:63\u201367","journal-title":"Toxicol Appl Pharmacol"},{"key":"2437_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","volume":"178","author":"K Allen","year":"2011","unstructured":"Allen K, Jaeschke H, Copple BL (2011) Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol 178:175\u2013186","journal-title":"Am J Pathol"},{"key":"2437_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1124\/dmd.104.001669","volume":"33","author":"PP Annaert","year":"2005","unstructured":"Annaert PP, Brouwer KL (2005) Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes. Drug Metab Dispos 33:388\u2013394","journal-title":"Drug Metab Dispos"},{"key":"2437_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1124\/dmd.109.030197","volume":"38","author":"S Anth\u00e9rieu","year":"2010","unstructured":"Anth\u00e9rieu S, Chesn\u00e9 C, Li R et al (2010) Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug Metab Dispos 38:516\u2013525","journal-title":"Drug Metab Dispos"},{"key":"2437_CR8","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.26160","volume":"57","author":"S Anth\u00e9rieu","year":"2013","unstructured":"Anth\u00e9rieu S, Bachour-El Azzi P, Dumont J et al (2013) Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells. Hepatology 57:1518\u20131529","journal-title":"Hepatology"},{"key":"2437_CR9","doi-asserted-by":"publisher","first-page":"G119","DOI":"10.1152\/ajpgi.00253.2010","volume":"301","author":"A Arduini","year":"2011","unstructured":"Arduini A, Serviddio G, Escobar J et al (2011) Mitochondrial biogenesis fails in secondary biliary cirrhosis in rats leading to mitochondrial DNA depletion and deletions. Am J Physiol Gastrointest Liver Physiol 301:G119\u2013G127","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2437_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/toxsci\/kfv041","volume":"145","author":"P Bachour-El Azzi","year":"2015","unstructured":"Bachour-El Azzi P, Sharanek A, Burban A et al (2015) Comparative localization and functional activity of the main hepatobiliary transporters in HepaRG Cells and primary human hepatocytes. Toxicol Sci 145:157\u2013168","journal-title":"Toxicol Sci"},{"key":"2437_CR11","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1177\/1535370214531872","volume":"239","author":"SS Bale","year":"2014","unstructured":"Bale SS, Vernetti L, Senutovitch N et al (2014) In vitro platforms for evaluating liver toxicity. Exp Biol Med 239:1180\u20131191","journal-title":"Exp Biol Med"},{"key":"2437_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1089\/ten.tec.2018.0134","volume":"24","author":"A Baze","year":"2018","unstructured":"Baze A, Parmentier C, Hendriks DFG et al (2018) Three-dimensional spheroid primary human hepatocytes in monoculture and coculture with nonparenchymal cells. Tissue Eng Part C Methods 24:534\u2013545","journal-title":"Tissue Eng Part C Methods"},{"key":"2437_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","volume":"54","author":"K Begriche","year":"2011","unstructured":"Begriche K, Massart J, Robin MA, Borgne-Sanchez A et al (2011) Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 54:773\u2013794","journal-title":"J Hepatol"},{"key":"2437_CR14","doi-asserted-by":"publisher","first-page":"25187","DOI":"10.1038\/srep25187","volume":"6","author":"CC Bell","year":"2016","unstructured":"Bell CC, Hendriks DF, Moro SM et al (2016) Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep 6:25187","journal-title":"Sci Rep"},{"key":"2437_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/dmd.116.074369","volume":"45","author":"CC Bell","year":"2017","unstructured":"Bell CC, Lauschke VM, Vorrink SU et al (2017) Transcriptional, functional, and mechanistic comparisons of stem cell-derived hepatocytes, HepaRG cells, and three-dimensional human hepatocyte spheroids as predictive in vitro systems for drug-induced liver injury. Drug Metab Dispos 45:419\u2013429","journal-title":"Drug Metab Dispos"},{"key":"2437_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/toxsci\/kfx289","volume":"162","author":"CC Bell","year":"2018","unstructured":"Bell CC, Dankers ACA, Lauschke VM et al (2018) Comparison of hepatic 2D sandwich cultures and 3D spheroids for long-term toxicity applications: a multicenter study. Toxicol Sci 162:655\u2013666","journal-title":"Toxicol Sci"},{"key":"2437_CR17","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2217\/fon.13.274","volume":"10","author":"P Benien","year":"2014","unstructured":"Benien P, Swami A (2014) 3D tumor models: history, advances and future perspectives. Future Oncol 10:1311\u20131327","journal-title":"Future Oncol"},{"key":"2437_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","volume":"5","author":"E Birben","year":"2012","unstructured":"Birben E, Sahiner UM, Sackesen C et al (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5:9\u201319","journal-title":"World Allergy Organ J"},{"key":"2437_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.cld.2013.07.015","volume":"17","author":"KR Bhamidimarri","year":"2013","unstructured":"Bhamidimarri KR, Schiff E (2013) Drug-induced cholestasis. Clin Liver Dis 17:519\u2013531","journal-title":"Clin Liver Dis"},{"key":"2437_CR20","first-page":"58","volume":"1867","author":"TA Bhat","year":"2017","unstructured":"Bhat TA, Chaudhary AK, Kumar S et al (2017) Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer. Biochim Biophys Acta 1867:58\u201366","journal-title":"Biochim Biophys Acta"},{"key":"2437_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/hep.22674","volume":"49","author":"CM Brophy","year":"2009","unstructured":"Brophy CM, Luebke-Wheeler JL, Amiot BP et al (2009) Rat hepatocyte spheroids formed by rocket technique maintain differentiated hepatocyte gene expression and function. Hepatology 49:578\u2013586","journal-title":"Hepatology"},{"key":"2437_CR22","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/s41598-017-01171-y","volume":"7","author":"A Burban","year":"2017","unstructured":"Burban A, Sharanek A, Hue R et al (2017) Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC\/P38 and PI3K\/AKT signaling pathways. Sci Rep 7:1815","journal-title":"Sci Rep"},{"key":"2437_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2017.11.017","volume":"115","author":"A Burban","year":"2018","unstructured":"Burban A, Sharanek A, Guguen-Guillouzo C et al (2018) Endoplasmic reticulum stress precedes oxidative stress in antibiotic-induced cholestasis and cytotoxicity in human hepatocytes. Free Radic Biol Med 115:166\u2013178","journal-title":"Free Radic Biol Med"},{"key":"2437_CR24","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1124\/dmd.116.071373","volume":"44","author":"MG Burbank","year":"2016","unstructured":"Burbank MG, Burban A, Sharanek A et al (2016) Early alterations of bile canaliculi dynamics and the rho kinase\/myosin light chain kinase pathway are characteristics of drug-induced intrahepatic cholestasis. Drug Metab Dispos 44:1780\u20131793","journal-title":"Drug Metab Dispos"},{"key":"2437_CR25","unstructured":"Cai J, DeLaForest A, Fisher J et al (2012) Protocol for directed dedifferentiation of human pluripotent stem cells toward a hepatocyte facte. In: StemBook (Harvard Stem Cell Institute)"},{"key":"2437_CR26","doi-asserted-by":"publisher","first-page":"e90780","DOI":"10.1172\/jci.insight.90780","volume":"2","author":"SY Cai","year":"2017","unstructured":"Cai SY, Ouyang X, Chen Y et al (2017) Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response. JCI Insight 2:e90780","journal-title":"JCI Insight"},{"key":"2437_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1517\/17425255.2.2.183","volume":"2","author":"JV Castell","year":"2006","unstructured":"Castell JV, Jover R, Martinez-Jimenez CP et al (2006) Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opin Drug Metab Toxicol 2:183\u2013212","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2437_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2174\/1389200219666180427165035","volume":"19","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, Annaert P (2018) Drug-induced cholestasis: mechanisms, models and markers. Curr Drug Metab 19:808\u2013818","journal-title":"Curr Drug Metab"},{"key":"2437_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","volume":"274","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Richert L, Augustijns P et al (2014) Hepatocyte-based in vitro model for assessment of drug-induced cholestasis. Toxicol Appl Pharmacol 274:124\u2013136","journal-title":"Toxicol Appl Pharmacol"},{"key":"2437_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.taap.2009.06.022","volume":"240","author":"X Chen","year":"2009","unstructured":"Chen X, Zhang C, Wang H et al (2009) Altered integrity and decreased expression of hepatocyte tight junctions in rifampicin-induced cholestasis in mice. Toxicol Appl Pharmacol 240:26\u201336","journal-title":"Toxicol Appl Pharmacol"},{"key":"2437_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0030-1253228","volume":"30","author":"BL Copple","year":"2010","unstructured":"Copple BL, Jaeschke H, Klaassen CD (2010) Oxidative stress and the pathogenesis of cholestasis. Semin Liver Dis 30:195\u2013204","journal-title":"Semin Liver Dis"},{"key":"2437_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1124\/dmd.113.056358","volume":"42","author":"FJ Cuperus","year":"2014","unstructured":"Cuperus FJ, Claudel T, Gautherot J et al (2014) The role of canalicular ABC transporters in cholestasis. Drug Metab Dispos 42:546\u2013560","journal-title":"Drug Metab Dispos"},{"key":"2437_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/B978-0-12-804667-8.00007-9","volume":"2018","author":"S Das","year":"2018","unstructured":"Das S (2018) Chapter 7: extrapolation of in vitro results to predict human toxicity. In Vitro Toxicol 2018:127\u2013142","journal-title":"In Vitro Toxicol"},{"key":"2437_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/hmg\/9.8.1209","volume":"9","author":"PH Dixon","year":"2000","unstructured":"Dixon PH, Weerasekera N, Linton KJ et al (2000) Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 9:1209\u20131217","journal-title":"Hum Mol Genet"},{"key":"2437_CR35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1517\/17425255.2013.773973","volume":"9","author":"T Bruyn De","year":"2013","unstructured":"De Bruyn T, Chatterjee S, Fattah S et al (2013) Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 9:589\u2013616","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2437_CR88","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1517\/17425255.2014.939956","volume":"10","author":"TVM Lima de","year":"2014","unstructured":"de Lima TVM, Tagliati CA (2014) Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools. Expert Opin Drug Metab Toxicol 10:581\u2013597","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2437_CR36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.2174\/1389200211314090002","volume":"14","author":"MT Donato","year":"2013","unstructured":"Donato MT, Jover R, Gomez-Lechon MJ (2013) Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering. Curr Drug Metab 14:946\u2013968","journal-title":"Curr Drug Metab"},{"key":"2437_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.biomaterials.2007.09.016","volume":"29","author":"Y Du","year":"2008","unstructured":"Du Y, Han R, Wen F et al (2008) Synthetic sandwich culture of 3D hepatocyte monolayer. Biomaterials 29:290\u2013301","journal-title":"Biomaterials"},{"key":"2437_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clinre.2014.07.011","volume":"39","author":"S Erlinger","year":"2015","unstructured":"Erlinger S (2015) NTCP deficiency: a new inherited disease of bile acid transport. Clin Res Hepatol Gastroenterol 39:7\u20138","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2437_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European Association for the Study of the Liver","year":"2009","unstructured":"European Association for the Study of the Liver (2009) EASL Clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 51:237\u2013267","journal-title":"J Hepatol"},{"key":"2437_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9440(10)64868-7","volume":"160","author":"P Fickert","year":"2002","unstructured":"Fickert P, Trauner M, Fuchsbichler A et al (2002) Cytokeratins as targets for bile acid-induced toxicity. Am J Pathol 160:491\u2013499","journal-title":"Am J Pathol"},{"key":"2437_CR41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00204-012-0983-3","volume":"87","author":"J Fraczek","year":"2013","unstructured":"Fraczek J, Bolleyn J, Vanhaecke T et al (2013) Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies. Arch Toxicol 87:577\u2013610","journal-title":"Arch Toxicol"},{"key":"2437_CR42","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.biomaterials.2005.07.031","volume":"27","author":"J Fukuda","year":"2006","unstructured":"Fukuda J, Sakai Y, Nakazawa K (2006) Novel hepatocyte culture system developed using microfabrication and collagen\/polyethylene glycol microcontact printing. Biomaterials 27:1061\u20131070","journal-title":"Biomaterials"},{"key":"2437_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/2045-3701-4-47","volume":"4","author":"L Gao","year":"2014","unstructured":"Gao L, Lv G, Guo X et al (2014) Activation of autophagy protects against cholestasis-induced hepatic injury. Cell Biosci 4:47","journal-title":"Cell Biosci"},{"key":"2437_CR44","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.stemcr.2017.10.019","volume":"9","author":"Y Gao","year":"2017","unstructured":"Gao Y, Zhang X, Zhang L et al (2017) Distinct gene expression and epigenetic signatures in hepatocyte-like cells produced by different strategies from the same donor. Stem Cell Reports 9:1813\u20131824","journal-title":"Stem Cell Reports"},{"key":"2437_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1124\/dmd.113.054189","volume":"42","author":"B Garzel","year":"2014","unstructured":"Garzel B, Yang H, Zhang L et al (2014) The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity. Drug Metab Dispos 42:318\u2013322","journal-title":"Drug Metab Dispos"},{"key":"2437_CR46","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","volume":"87","author":"P Godoy","year":"2013","unstructured":"Godoy P, Hewitt NJ, Albrecht U et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87:1315\u20131530","journal-title":"Arch Toxicol"},{"key":"2437_CR47","doi-asserted-by":"crossref","first-page":"83951","DOI":"10.18632\/oncotarget.13796","volume":"7","author":"Z Gong","year":"2016","unstructured":"Gong Z, Zhou J, Zhao S et al (2016) Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis. Oncotarget 7:83951\u201383963","journal-title":"Oncotarget"},{"key":"2437_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/toxsci\/kfs188","volume":"129","author":"R Greupink","year":"2012","unstructured":"Greupink R, Nabuurs SB, Zarzycka B et al (2012) In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificity. Toxicol Sci 129:35\u201348","journal-title":"Toxicol Sci"},{"key":"2437_CR49","doi-asserted-by":"publisher","first-page":"15655","DOI":"10.1073\/pnas.232137699","volume":"99","author":"P Gripon","year":"2002","unstructured":"Gripon P, Rumin S, Urban S et al (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Nati Acad Sci USA 99:15655\u201315660","journal-title":"Proc Nati Acad Sci USA"},{"key":"2437_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60761-688-7_1","volume":"640","author":"C Guguen-Guillouzo","year":"2010","unstructured":"Guguen-Guillouzo C, Guillouzo A (2010) General review on in vitro hepatocyte models and their applications. Methods Mol Biol 640:1\u201340","journal-title":"Methods Mol Biol"},{"key":"2437_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.tox.2009.09.019","volume":"270","author":"C Guguen-Guillouzo","year":"2010","unstructured":"Guguen-Guillouzo C, Corlu A, Guillouzo A (2010) Stem cell-derived hepatocytes and their use in toxicology. Toxicology 270:3\u20139","journal-title":"Toxicology"},{"key":"2437_CR52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/jhep.2003.50341","volume":"38","author":"JS Gujral","year":"2003","unstructured":"Gujral JS, Farhood A, Bajt ML et al (2003) Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 38:355\u2013363","journal-title":"Hepatology"},{"key":"2437_CR53","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.1840400431","volume":"40","author":"JS Gujral","year":"2004","unstructured":"Gujral JS, Liu J, Farhood A et al (2004) Reduced oncotic necrosis in Fas receptor-deficient C57BL\/6J-lpr mice after bile duct ligation. Hepatology 40:998\u20131007","journal-title":"Hepatology"},{"key":"2437_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/toxsci\/kft021","volume":"133","author":"P Gunness","year":"2013","unstructured":"Gunness P, Mueller D, Shevchenko V et al (2013) 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. Toxicol Sci 133:67\u201378","journal-title":"Toxicol Sci"},{"key":"2437_CR55","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.mito.2004.07.015","volume":"4","author":"T Hassanein","year":"2004","unstructured":"Hassanein T, Frederick T (2004) Mitochondrial dysfunction in liver disease and organ transplantation. Mitochondrion 4:609\u2013620","journal-title":"Mitochondrion"},{"key":"2437_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cld.2012.12.001","volume":"17","author":"E Halilbasic","year":"2013","unstructured":"Halilbasic E, Baghdasaryan A, Trauner M (2013) Nuclear receptors as drug targets in cholestatic liver diseases. Clin Liver Dis 17:161\u2013189","journal-title":"Clin Liver Dis"},{"key":"2437_CR57","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nprot.2012.153","volume":"8","author":"NRF Hannan","year":"2013","unstructured":"Hannan NRF, Segeritz CP, Touboul T et al (2013) Production of hepatocyte like cells from human pluripotent stem cells. Nat Protoc 8:430\u2013437","journal-title":"Nat Protoc"},{"key":"2437_CR58","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/10763270152436445","volume":"7","author":"V Hasirci","year":"2001","unstructured":"Hasirci V, Berthiaume F, Bondre DP et al (2001) Expression of liver-specific functions by rat hepatocytes seeded in treated poly (lactic-co-glycocholic) acid biodegradable foams. Tissue Eng 7:379\u2013386","journal-title":"Tissue Eng"},{"key":"2437_CR59","doi-asserted-by":"publisher","first-page":"35434","DOI":"10.1038\/srep35434","volume":"6","author":"DFG Hendriks","year":"2016","unstructured":"Hendriks DFG, Puigvert LF, Messner S et al (2016) Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Sci Rep 6:35434","journal-title":"Sci Rep"},{"key":"2437_CR60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1081\/DMR-100100564","volume":"32","author":"JG Hengstler","year":"2000","unstructured":"Hengstler JG, Utesch D, Steinberg P et al (2000) Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev 32:81\u2013118","journal-title":"Drug Metab Rev"},{"key":"2437_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-0521-8_2","volume":"2014","author":"JG Hengstler","year":"2014","unstructured":"Hengstler JG, Hammad S, Ghallab A et al (2014) In vitro systems for hepatotoxicity testing. Vitro Toxicol Syst 2014:27\u201344","journal-title":"Vitro Toxicol Syst"},{"key":"2437_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jcmgh.2016.11.006","volume":"3","author":"AS Henkel","year":"2017","unstructured":"Henkel AS, LeCuyer B, Olivares S et al (2017) Endoplasmic reticulum stress regulates hepatic bile acid metabolism in mice. Cell Mol Gastroenterol Hepatol 3:261\u2013271","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2437_CR63","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1023\/B:PHAM.0000033018.97745.0d","volume":"21","author":"KA Hoffmaster","year":"2004","unstructured":"Hoffmaster KA, Turncliff RZ, Lecluyse EL et al (2004) P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide. Pharm Res 21:1294\u20131302","journal-title":"Pharm Res"},{"key":"2437_CR64","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","volume":"14","author":"P Huang","year":"2014","unstructured":"Huang P, Zhang L, Gao Y et al (2014) Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 14:370\u2013384","journal-title":"Cell Stem Cell"},{"key":"2437_CR65","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jchromb.2012.05.015","volume":"899","author":"L Humbert","year":"2012","unstructured":"Humbert L, Maubert MA, Wolf C et al (2012) Bile acid profiling in human biological samples: comparison of extraction procedures and application to normal and cholestatic patients. J Chromatogr B Analyt Technol Biomed Life Sci 899:135\u2013145","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2437_CR66","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1023\/A:1026639716440","volume":"44","author":"H Hyogo","year":"1999","unstructured":"Hyogo H, Tazuma S, Kajiyama G et al (1999) Transcytotic vesicle fusion is reduced in cholestatic rats: redistribution of phospholipids in the canalicular membrane. Dig Dis Sci 44:1662\u20131668","journal-title":"Dig Dis Sci"},{"key":"2437_CR67","doi-asserted-by":"publisher","first-page":"41806","DOI":"10.1038\/srep41806","volume":"7","author":"K Imagawa","year":"2017","unstructured":"Imagawa K, Takayma K, Isoyama S et al (2017) Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells. Sci Rep 7:41806","journal-title":"Sci Rep"},{"key":"2437_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1440-1746.2010.06592.x","volume":"1","author":"H Jaeschke","year":"2011","unstructured":"Jaeschke H (2011) Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 1:173\u2013179","journal-title":"J Gastroenterol Hepatol"},{"key":"2437_CR69","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/0016-5085(83)90429-8","volume":"85","author":"H Jaeschke","year":"1983","unstructured":"Jaeschke H, Krell H, Pfaff E (1983) No increase of biliary permeability in ethinylestradiol-treated rats. Gastroenterology 85:808\u2013814","journal-title":"Gastroenterology"},{"key":"2437_CR70","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0016-5085(87)90916-4","volume":"93","author":"H Jaeschke","year":"1987","unstructured":"Jaeschke H, Trummer E, Krell H (1987) Increase in biliary permeability subsequent to intrahepatic cholestasis by estradiol valerate in rats. Gastroenterology 93:533\u2013538","journal-title":"Gastroenterology"},{"key":"2437_CR71","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.28965","volume":"65","author":"PL Jansen","year":"2017","unstructured":"Jansen PL, Ghallab A, Vartak N et al (2017) The ascending pathophysiology of cholestatic liver disease. Hepatology 65:722\u2013738","journal-title":"Hepatology"},{"key":"2437_CR72","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2131\/jts.42.427","volume":"42","author":"T Kawamoto","year":"2017","unstructured":"Kawamoto T, Ito Y, Morita O et al (2017) Mechanism-based risk assessment strategy for drug-induced cholestasis using the transcriptional benchmark dose derived by toxicogenomics. J Toxicol Sci 42:427\u2013436","journal-title":"J Toxicol Sci"},{"key":"2437_CR73","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/0955-0674(95)80071-9","volume":"7","author":"GM Keller","year":"1995","unstructured":"Keller GM (1995) In vitro differentiation of embyronic stem cells. Curr Opin Cell Biol 7:862\u2013869","journal-title":"Curr Opin Cell Biol"},{"key":"2437_CR74","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tibtech.2004.02.002","volume":"22","author":"JM Kelm","year":"2004","unstructured":"Kelm JM, Fussenegger M (2004) Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol 22:195\u2013202","journal-title":"Trends Biotechnol"},{"key":"2437_CR75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/bit.10655","volume":"83","author":"JM Kelm","year":"2003","unstructured":"Kelm JM, Timmins NE, Brown CJ et al (2003) Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83:173\u2013180","journal-title":"Biotechnol Bioeng"},{"key":"2437_CR76","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1365-2125.2012.04360.x","volume":"75","author":"R Kia","year":"2013","unstructured":"Kia R, Sison RLC, Heslop J et al (2013) Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet? Br J Clin Pharmacol 75:885\u2013896","journal-title":"Br J Clin Pharmacol"},{"key":"2437_CR77","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/toxsci\/kfj111","volume":"90","author":"ND Kim","year":"2006","unstructured":"Kim ND, Moon JO, Slitt AL et al (2006) Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci 90:586\u2013595","journal-title":"Toxicol Sci"},{"key":"2437_CR78","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1124\/dmd.113.054304","volume":"42","author":"K K\u00f6ck","year":"2014","unstructured":"K\u00f6ck K, Ferslew BC, Netterberg I et al (2014) Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4. Drug Metab Dispos 42:665\u2013674","journal-title":"Drug Metab Dispos"},{"key":"2437_CR79","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1021\/acs.jcim.6b00518","volume":"57","author":"E Kotsampasakou","year":"2017","unstructured":"Kotsampasakou E, Ecker GF (2017) Predicting drug-induced cholestasis with the help of hepatic transporters\u2014an in silico modeling approach. J Chem Inf Model 57:608\u2013615","journal-title":"J Chem Inf Model"},{"key":"2437_CR80","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0016-5085(82)80400-9","volume":"82","author":"H Krell","year":"1982","unstructured":"Krell H, H\u00f6ke H, Pfaff E (1982) Development of intrahepatic cholestasis by alpha-naphthylisothiocyanate in rats. Gastroenterology 82:507\u2013514","journal-title":"Gastroenterology"},{"key":"2437_CR81","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.blre.2004.03.001","volume":"19","author":"U Lakshmipathy","year":"2005","unstructured":"Lakshmipathy U, Verfaillie C (2005) Stem cell plasticity. Blood Rev 19:29\u201338","journal-title":"Blood Rev"},{"key":"2437_CR82","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1083\/jcb.101.3.914","volume":"101","author":"J Landry","year":"1985","unstructured":"Landry J, Bernier D, Ouellet C et al (1985) Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J Cell Biol 101:914\u2013923","journal-title":"J Cell Biol"},{"key":"2437_CR83","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","volume":"17","author":"C Lang","year":"2007","unstructured":"Lang C, Meier Y, Stieger B et al (2007) Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics 17:47\u201360","journal-title":"Pharmacogenet Genomics"},{"key":"2437_CR84","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00228-010-0862-x","volume":"66","author":"HG Laverty","year":"2010","unstructured":"Laverty HG, Antoine DJ, Benson C et al (2010) The potential of cytokines as safety biomarkers for drug-induced liver injury. Eur J Clin Pharmacol 66:961\u2013976","journal-title":"Eur J Clin Pharmacol"},{"key":"2437_CR85","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0300-483X(00)00316-4","volume":"153","author":"C Lerche-Legrand","year":"2000","unstructured":"Lerche-Legrand C, Toutain HJ (2000) Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology 153:221\u2013253","journal-title":"Toxicology"},{"key":"2437_CR86","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","volume":"74","author":"T Li","year":"2015","unstructured":"Li T, Apte U (2015) Bile acid metabolism and signaling in cholestasis, inflammation, and cancer. Adv Pharmacol 74:263\u2013302","journal-title":"Adv Pharmacol"},{"key":"2437_CR87","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.molimm.2017.02.018","volume":"85","author":"P Li","year":"2017","unstructured":"Li P, He K, Li J et al (2017) The role of Kupffer cells in hepatic diseases. Mol Immunol 85:222\u2013229","journal-title":"Mol Immunol"},{"key":"2437_CR89","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1310050","volume":"370","author":"A Linkermann","year":"2014","unstructured":"Linkermann A, Green DR (2014) Necroptosis. N Engl J Med 370:455\u2013465","journal-title":"N Engl J Med"},{"key":"2437_CR90","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","volume":"54","author":"H Malhi","year":"2011","unstructured":"Malhi H, Kaufman RJ (2011) Endoplasmic reticulum stress in liver disease. J Hepatol 54:795\u2013809","journal-title":"J Hepatol"},{"key":"2437_CR91","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/toxsci\/kft246","volume":"137","author":"S Manley","year":"2014","unstructured":"Manley S, Ni HM, Kong B et al (2014) Suppression of autophagic flux by bile acids in hepatocytes. Toxicol Sci 137:478\u2013490","journal-title":"Toxicol Sci"},{"key":"2437_CR92","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","volume":"1864","author":"V Mariotti","year":"2017","unstructured":"Mariotti V, Strazzabosco M, Fabris L et al (2017) Animal models of biliary injury and altered bile acid metabolism. Biochim Biophys Acta 1864:1254\u20131261","journal-title":"Biochim Biophys Acta"},{"key":"2437_CR93","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00204-012-0968-2","volume":"87","author":"S Messner","year":"2013","unstructured":"Messner S, Agarkova I, Moritz W et al (2013) Multi-cell type human liver microtissues for hepatotoxicity testing. Arch Toxicol 87:209\u2013213","journal-title":"Arch Toxicol"},{"key":"2437_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/aivt.2017.0022","volume":"4","author":"S Messner","year":"2018","unstructured":"Messner S, Fredriksson L, Lauschke VM et al (2018) Transcriptomic, proteomic, and functional long-term characterization of multicellular three-dimensional human liver microtissues. Applied In Vitro Toxicology 4:1\u201312","journal-title":"Applied In Vitro Toxicology"},{"key":"2437_CR95","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/labinvest.2010.163","volume":"91","author":"C Mitchell","year":"2011","unstructured":"Mitchell C, Mahrouf-Yorgov M, Mayeuf A et al (2011) Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease. Lab Invest 91:273\u2013282","journal-title":"Lab Invest"},{"key":"2437_CR96","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","volume":"118","author":"RE Morgan","year":"2010","unstructured":"Morgan RE, Trauner M, van Staden CJ et al (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci 118:485\u2013500","journal-title":"Toxicol Sci"},{"key":"2437_CR97","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0014-4827(61)90122-7","volume":"22","author":"A Moscona","year":"1961","unstructured":"Moscona A (1961) Rotation-mediated histogenetic aggregation of dissociated cells. A quantifiable approach to cell interactions in vitro. Exp Cell Res 22:455\u2013475","journal-title":"Exp Cell Res"},{"key":"2437_CR98","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1053\/jhep.2002.33327","volume":"35","author":"AD Mottino","year":"2002","unstructured":"Mottino AD, Cao J, Veggi LM et al (2002) Altered localization and activity of canalicular Mrp2 in estradiol-17\u03b2-d-glucuronide-induced cholestasis. Hepatology 35:1409\u20131419","journal-title":"Hepatology"},{"key":"2437_CR99","doi-asserted-by":"publisher","first-page":"G391","DOI":"10.1152\/ajpgi.00496.2006","volume":"293","author":"AD Mottino","year":"2007","unstructured":"Mottino AD, Hoffman T, Crocenzi FA et al (2007) Disruption of function and localization of tight junctional structures and Mrp2 in sustained estradiol-17\u03b2-D-glucuronide-induced cholestasis. Am J Physiol Gastrointest Liver Physiol 293:G391\u2013G402","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2437_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.tiv.2015.04.014","volume":"30","author":"SO Mueller","year":"2015","unstructured":"Mueller SO, Guillouzo A, Hewitt PG et al (2015) Drug biokinetic and toxicity assessments in rat and human primary hepatocytes and HepaRG cells within the EU-funded Predict-IV project. Toxicol In Vitro 30:19\u201326","journal-title":"Toxicol In Vitro"},{"key":"2437_CR101","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.toxlet.2017.11.014","volume":"284","author":"A Natale","year":"2018","unstructured":"Natale A, Boeckmans J, Desmae T et al (2018) Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone. Toxicol Lett 284:184\u2013194","journal-title":"Toxicol Lett"},{"key":"2437_CR102","doi-asserted-by":"publisher","first-page":"9418","DOI":"10.3748\/wjg.v20.i30.10279","volume":"20","author":"KD Nguyen","year":"2014","unstructured":"Nguyen KD, Sundaram V, Ayoub WS (2014) Atypical causes of cholestasis. World J Gastroenterol 20:9418\u20139426","journal-title":"World J Gastroenterol"},{"key":"2437_CR103","doi-asserted-by":"publisher","first-page":"38694","DOI":"10.1038\/srep38694","volume":"6","author":"X Ni","year":"2016","unstructured":"Ni X, Gao Y, Wu Z et al (2016) Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: a novel in vitro cholestatic model. Sci Rep 6:38694","journal-title":"Sci Rep"},{"key":"2437_CR104","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1113\/JP271124","volume":"593","author":"F Noor","year":"2015","unstructured":"Noor F (2015) A shift in paradigm towards human biology-based systems for cholestatic-liver diseases. J Physiol 593:5043\u20135055","journal-title":"J Physiol"},{"key":"2437_CR105","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ejps.2008.01.008","volume":"33","author":"P Olinga","year":"2008","unstructured":"Olinga P, Elferink MG, Draaisma AL et al (2008) Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. Eur J Pharm Sci 33:380\u2013389","journal-title":"Eur J Pharm Sci"},{"key":"2437_CR106","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/rtph.2000.1399","volume":"32","author":"H Olson","year":"2000","unstructured":"Olson H, Betton G, Robinson D et al (2000) Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32:56\u201367","journal-title":"Regul Toxicol Pharmacol"},{"key":"2437_CR107","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.vascn.2015.03.002","volume":"73","author":"M Oorts","year":"2015","unstructured":"Oorts M, Richert L, Annaert P (2015) Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture. J Pharmacol Toxicol Methods 73:63\u201371","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2437_CR108","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.tiv.2016.03.008","volume":"2016","author":"M Oorts","year":"2016","unstructured":"Oorts M, Baze A, Bachellier P et al (2016) Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes. Toxicol In Vitro 2016:179\u2013186","journal-title":"Toxicol In Vitro"},{"key":"2437_CR109","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","volume":"245","author":"J Ozer","year":"2008","unstructured":"Ozer J, Ratner M, Shaw M et al (2008) The current state of serum biomarkers of hepatotoxicity. Toxicology 245:194\u2013205","journal-title":"Toxicology"},{"key":"2437_CR110","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/hep.24229","volume":"53","author":"MS Padda","year":"2011","unstructured":"Padda MS, Sanchez M, Akhtar AJ et al (2011) Drug-induced cholestasis. Hepatology 53:1377\u20131387","journal-title":"Hepatology"},{"key":"2437_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2004.06.001","volume":"203","author":"CM Palmeira","year":"2004","unstructured":"Palmeira CM, Rolo AP (2004) Mitochondrially-mediated toxicity of bile acids. Toxicology 203:1\u201315","journal-title":"Toxicology"},{"key":"2437_CR112","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2004.01.002","volume":"126","author":"R Parent","year":"2004","unstructured":"Parent R, Marion MJ, Furio L et al (2004) Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 126:1147\u20131156","journal-title":"Gastroenterology"},{"key":"2437_CR113","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1124\/dmd.113.052415","volume":"41","author":"C Parmentier","year":"2013","unstructured":"Parmentier C, Truisi GL, Moenks K et al (2013) Transcriptomic hepatotoxicity signature of chlorpromazine after short-and long-term exposure in primary human sandwich cultures. Drug Metab Dispos 41:1835\u20131842","journal-title":"Drug Metab Dispos"},{"key":"2437_CR114","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.toxlet.2018.06.1069","volume":"295","author":"C Parmentier","year":"2018","unstructured":"Parmentier C, Hendriks DFG, Heyd B et al (2018) Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent. Toxicol Lett 295:187\u2013194","journal-title":"Toxicol Lett"},{"key":"2437_CR115","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/hep.21359","volume":"44","author":"C Pauli-Magnus","year":"2006","unstructured":"Pauli-Magnus C, Meier PJ (2006) Hepatobiliary transporters and drug-induced cholestasis. Hepatology 44:778\u2013787","journal-title":"Hepatology"},{"key":"2437_CR116","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3748\/wjg.15.1677","volume":"15","author":"MJ Perez","year":"2009","unstructured":"Perez MJ, Briz O (2009) Bile-acid-induced cell injury and protection. World J Gastroenterol 15:1677\u20131689","journal-title":"World J Gastroenterol"},{"key":"2437_CR118","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1517\/17425255.2012.648613","volume":"8","author":"KR Przybylak","year":"2012","unstructured":"Przybylak KR, Cronin MT (2012) In silico models for drug-induced liver injury\u2013current status. Expert Opin Drug Metab Toxicol 8:201\u2013217","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2437_CR117","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1021\/acs.molpharmaceut.5b00659","volume":"13","author":"X Qiu","year":"2016","unstructured":"Qiu X, Zhang Y, Liu T et al (2016) Disruption of BSEP function in HepaRG cells alters bile acid disposition and is a susceptive factor to drug-induced cholestatic injury. Mol Pharm 13:1206\u20131216","journal-title":"Mol Pharm"},{"key":"2437_CR119","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/03602532.2012.756010","volume":"45","author":"E Ramboer","year":"2013","unstructured":"Ramboer E, Vanhaecke T, Rogiers V et al (2013) Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters. Drug Metab Rev 45:196\u2013217","journal-title":"Drug Metab Rev"},{"key":"2437_CR120","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2012.07.007","volume":"150","author":"AK Rathinam Vijay","year":"2012","unstructured":"Rathinam Vijay AK, Vanaja Sivapriya K, Waggoner L et al (2012) TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150:606\u2013619","journal-title":"Cell"},{"key":"2437_CR121","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1089\/scd.2013.0157","volume":"23","author":"RM Rodrigues","year":"2013","unstructured":"Rodrigues RM, De Kock J, Branson S et al (2013) Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals. Stem Cells Dev 23:44\u201355","journal-title":"Stem Cells Dev"},{"key":"2437_CR122","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.tiv.2014.10.012","volume":"29","author":"RM Rodrigues","year":"2015","unstructured":"Rodrigues RM, Sachinidis A, De Boe V et al (2015) Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors. Toxicol In Vitro 29:1231\u20131239","journal-title":"Toxicol In Vitro"},{"key":"2437_CR123","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00204-015-1483-z","volume":"90","author":"RM Rodrigues","year":"2016","unstructured":"Rodrigues RM, Branson S, De Boe V et al (2016) In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells. Arch Toxicol 90:677\u2013689","journal-title":"Arch Toxicol"},{"key":"2437_CR124","unstructured":"Russell WMS, Burch RL (1959) The principles of humane experimental technique"},{"key":"2437_CR125","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00535-014-1033-0","volume":"50","author":"M Sasaki","year":"2015","unstructured":"Sasaki M, Yoshimura-Miyakoshi M, Sato Y et al (2015) A possible involvement of endoplasmic reticulum stress in biliary epithelial autophagy and senescence in primary biliary cirrhosis. J Gastroenterol 50:984\u2013995","journal-title":"J Gastroenterol"},{"key":"2437_CR126","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.bbamem.2013.05.007","volume":"1828","author":"S Schulz","year":"2013","unstructured":"Schulz S, Schmitt S, Wimmer R et al (2013) Progressive stages of mitochondrial destruction caused by cell toxic bile salts. Biochim Biophys Acta 1828:2121\u20132133","journal-title":"Biochim Biophys Acta"},{"key":"2437_CR127","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0014-4827(76)90148-8","volume":"100","author":"PO Seglen","year":"1976","unstructured":"Seglen PO, Reith A (1976) Ammonia inhibition of protein degradation in isolated rat hepatocytes. Quantitative ultrastructural alterations in the lysosomal system. Exp Cell Res 100:276\u2013280","journal-title":"Exp Cell Res"},{"key":"2437_CR128","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/toxsci\/kfu122","volume":"141","author":"A Sharanek","year":"2014","unstructured":"Sharanek A, Azzi PB, Al-Attrache H et al (2014) Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in HepaRG cells. Toxicol Sci 141:244\u2013253","journal-title":"Toxicol Sci"},{"key":"2437_CR129","doi-asserted-by":"publisher","first-page":"24709","DOI":"10.1038\/srep24709","volume":"6","author":"A Sharanek","year":"2016","unstructured":"Sharanek A, Burban A, Burbank M et al (2016) Rho-kinase\/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs. Sci Rep 6:24709","journal-title":"Sci Rep"},{"key":"2437_CR130","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1124\/dmd.117.077420","volume":"45","author":"A Sharanek","year":"2017","unstructured":"Sharanek A, Burban A, Humbert L et al (2017) Progressive and preferential cellular accumulation of hydrophobic bile acids induced by cholestatic drugs is associated with inhibition of their amidation and sulfatation. Drug Metab Dispos 45:1292\u20131303","journal-title":"Drug Metab Dispos"},{"key":"2437_CR131","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/toxsci\/kfv136","volume":"147","author":"RL Sison-Young","year":"2015","unstructured":"Sison-Young RL, Mitsa D, Jenkins RE et al (2015) Comparative proteomic characterization of 4 human liver-derived single cell culture models reveals significant variation in the capacity of drug disposition, bioactivation and detoxication. Toxicol Sci 147:412\u2013424","journal-title":"Toxicol Sci"},{"key":"2437_CR132","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0168-8278(87)80043-0","volume":"5","author":"DJ Smith","year":"1987","unstructured":"Smith DJ, Gordon ER (1987) Membrane fluidity and cholestasis. J Hepatol 5:362\u2013365","journal-title":"J Hepatol"},{"key":"2437_CR133","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1634\/stemcells.2008-0963","volume":"27","author":"S Snykers","year":"2009","unstructured":"Snykers S, De Kock J, Rogiers V et al (2009) In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem cells 27:577\u2013605","journal-title":"Stem cells"},{"key":"2437_CR134","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-1-60761-999-4_23","volume":"698","author":"S Snykers","year":"2011","unstructured":"Snykers S, De Kock J, Vanhaecke V et al (2011) Hepatic differentiation of mesenchymal stem cells: in vitro strategies. Methods Mol Biol 698:305\u2013314","journal-title":"Methods Mol Biol"},{"key":"2437_CR135","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1039\/C2TX20051A","volume":"2","author":"VY Soldatow","year":"2013","unstructured":"Soldatow VY, LeCluyse EL, Griffith LG et al (2013) In vitro models for liver toxicity testing. Toxicol Res (Camb) 2:23\u201339","journal-title":"Toxicol Res (Camb)"},{"key":"2437_CR136","first-page":"277","volume":"71","author":"JY Song","year":"1996","unstructured":"Song JY, Van Marle J, Van Noorden CJ et al (1996) Redistribution of Ca2+, Mg2+-ATPase activity in relation to alterations of the cytoskeleton and tight junctions in hepatocytes of cholestatic rat liver. Eur J Cell Biol 71:277\u2013285","journal-title":"Eur J Cell Biol"},{"key":"2437_CR137","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1023\/A:1003455608511","volume":"30","author":"JY Song","year":"1998","unstructured":"Song JY, Van Noorden CJF, Frederiks WM (1998) The involvement of altered vesicle transport in redistribution of Ca2+, Mg2+-ATPase in cholestatic rat liver. Histochem J 30:909\u2013916","journal-title":"Histochem J"},{"key":"2437_CR138","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/cr.2009.107","volume":"19","author":"Z Song","year":"2009","unstructured":"Song Z, Cai J, Liu Y et al (2009) Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 19:1233\u20131242","journal-title":"Cell Res"},{"key":"2437_CR139","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1172\/JCI116546","volume":"92","author":"JR Spivey","year":"1993","unstructured":"Spivey JR, Bronk SF, Gores GJ (1993) Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest 92:17\u201324","journal-title":"J Clin Invest"},{"key":"2437_CR140","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1007\/s00204-017-1960-7","volume":"91","author":"V Starokozhko","year":"2017","unstructured":"Starokozhko V, Greupink R, van de Broek P et al (2017a) Rat precision-cut liver slices predict drug-induced cholestatic injury. Arch Toxicol 91:3403\u20133413","journal-title":"Arch Toxicol"},{"key":"2437_CR141","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00204-016-1865-x","volume":"91","author":"V Starokozhko","year":"2017","unstructured":"Starokozhko V, Vatakuti S, Schievink B et al (2017b) Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days. Arch Toxicol 91:2079\u20132092","journal-title":"Arch Toxicol"},{"key":"2437_CR142","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.4049\/jimmunol.171.11.6154","volume":"171","author":"C Stehlik","year":"2003","unstructured":"Stehlik C, Lee SH, Dorfleutner A et al (2003) Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol 171:6154\u20136163","journal-title":"J Immunol"},{"key":"2437_CR144","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00418-008-0431-x","volume":"129","author":"P Strnad","year":"2008","unstructured":"Strnad P, Stumptner C, Zatloukal K et al (2008) Intermediate filament cytoskeleton of the liver in health and disease. Histochem Cell Biol 129:735\u2013749","journal-title":"Histochem Cell Biol"},{"key":"2437_CR143","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/03602530903491881","volume":"42","author":"B Swift","year":"2010","unstructured":"Swift B, Pfeifer ND, Brouwer KLR (2010) Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42:446\u2013471","journal-title":"Drug Metab Rev"},{"key":"2437_CR145","doi-asserted-by":"publisher","first-page":"e59432","DOI":"10.1371\/journal.pone.0059432","volume":"8","author":"M Szabo","year":"2013","unstructured":"Szabo M, Veres Z, Baranyai Z et al (2013) Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity. PLoS One 8:e59432","journal-title":"PLoS One"},{"key":"2437_CR146","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1755-8794-6-39","volume":"6","author":"E Szalowska","year":"2013","unstructured":"Szalowska E, Stoopen G, Groot MJ et al (2013) Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes. BMC Med Genom 6:39","journal-title":"BMC Med Genom"},{"key":"2437_CR147","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.95.1.282","volume":"95","author":"JM Vree de","year":"1998","unstructured":"de Vree JM, Jacquemin E, Sturm E et al (1998) Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 95:282\u2013287","journal-title":"Proc Natl Acad Sci USA"},{"key":"2437_CR148","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1515\/CCLM.2003.247","volume":"41","author":"D Tagliacozzi","year":"2003","unstructured":"Tagliacozzi D, Mozzi AF, Casetta B et al (2003) Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method. Clin Chem Lab Med 41:1633\u20131641","journal-title":"Clin Chem Lab Med"},{"key":"2437_CR149","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663\u2013676","journal-title":"Cell"},{"key":"2437_CR150","doi-asserted-by":"crossref","first-page":"e00208","DOI":"10.1042\/BSR20150034","volume":"35","author":"Y Takahashi","year":"2015","unstructured":"Takahashi Y, Hori Y, Yamamoto T (2015) 3D spheroid cultures improve the metabolic gene expression profiles of HepaRG cells. Biosci Rep 35:e00208","journal-title":"Biosci Rep"},{"key":"2437_CR151","doi-asserted-by":"publisher","first-page":"G498","DOI":"10.1152\/ajpgi.00482.2007","volume":"294","author":"N Tamaki","year":"2008","unstructured":"Tamaki N, Hatano E, Taura K et al (2008) CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. Am J Physiol Gastrointest Liver Physiol 294:G498\u2013G505","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2437_CR152","first-page":"346","volume":"32","author":"MM Tiao","year":"2009","unstructured":"Tiao MM, Lin TK, Wang PW et al (2009) The role of mitochondria in cholestatic liver injury. Chang Gung Med J 32:346\u2013353","journal-title":"Chang Gung Med J"},{"key":"2437_CR153","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep.24760","volume":"55","author":"RM Tost\u00f5es","year":"2012","unstructured":"Tost\u00f5es RM, Leite SB, Serra M et al (2012) Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology 55:1227\u20131236","journal-title":"Hepatology"},{"key":"2437_CR154","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1152\/physrev.00027.2002","volume":"83","author":"M Trauner","year":"2003","unstructured":"Trauner M, Boyer JL (2003) Bile salt transporters: molecular characterization, function and regulation. Physiol Rev 83:663\u2013671","journal-title":"Physiol Rev"},{"key":"2437_CR155","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0016-5085(97)70103-3","volume":"113","author":"M Trauner","year":"1997","unstructured":"Trauner M, Arrese M, Soroka CJ et al (1997) The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113:255\u2013264","journal-title":"Gastroenterology"},{"key":"2437_CR156","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1021\/tx4004165","volume":"27","author":"WF Hof Van den","year":"2014","unstructured":"Van den Hof WF, Coonen ML, van Herwijnen M et al (2014) Classification of hepatotoxicants using HepG2 cells: a proof of principle study. Chem Res Toxicol 27:433\u2013442","journal-title":"Chem Res Toxicol"},{"key":"2437_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4254\/wjh.v2.i1.1","volume":"2","author":"F Zijl van","year":"2010","unstructured":"van Zijl F, Mikulits W (2010) Hepatospheres: three dimensional cell cultures resemble physiological conditions of the liver. World J Hepatol 2:1\u20137","journal-title":"World J Hepatol"},{"key":"2437_CR158","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/hep.28373","volume":"63","author":"N Vartak","year":"2016","unstructured":"Vartak N, Damle-Vartak A, Richter B et al (2016) Cholestasis-induced adaptive remodeling of interlobular bile ducts. Hepatology 63:951\u2013964","journal-title":"Hepatology"},{"key":"2437_CR159","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/acs.chemrestox.5b00491","volume":"29","author":"S Vatakuti","year":"2016","unstructured":"Vatakuti S, Pennings JL, Gore E et al (2016) Classification of cholestatic and necrotic hepatotoxicants using transcriptomics on human precision-cut liver slices. Chem Res Toxicol 29:342\u2013351","journal-title":"Chem Res Toxicol"},{"key":"2437_CR160","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-016-1778-8","volume":"91","author":"S Vatakuti","year":"2017","unstructured":"Vatakuti S, Olinga P, Pennings JL et al (2017) Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach. Arch Toxicol 91:1401\u20131412","journal-title":"Arch Toxicol"},{"key":"2437_CR161","first-page":"247","volume":"320","author":"M Vinken","year":"2006","unstructured":"Vinken M, Elaut G, Henkens T et al (2006) Rat hepatocyte cultures: collagen gel sandwich and immobilization cultures. Methods Mol Biol 320:247\u2013254","journal-title":"Methods Mol Biol"},{"key":"2437_CR162","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/toxsci\/kft177","volume":"136","author":"M Vinken","year":"2013","unstructured":"Vinken M, Landesmann B, Goumenou M et al (2013) Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury. Toxicol Sci 136:97\u2013106","journal-title":"Toxicol Sci"},{"key":"2437_CR163","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1096\/fj.201601375R","volume":"31","author":"SU Vorrink","year":"2017","unstructured":"Vorrink SU, Ullah S, Schmidt S et al (2017) Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics. FASEB J 31:2696\u20132708","journal-title":"FASEB J"},{"key":"2437_CR164","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/toxsci\/kfy058","volume":"163","author":"SU Vorrink","year":"2018","unstructured":"Vorrink SU, Zhou Y, Ingelman-Sundberg M et al (2018) Prediction of drug-induced hepatotoxicity using long-term stable primary hepatic 3D spheroid cultures in chemically defined conditions. Toxicol Sci 163:655\u2013665","journal-title":"Toxicol Sci"},{"key":"2437_CR165","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","volume":"51","author":"M Wagner","year":"2009","unstructured":"Wagner M, Zollner G, Trauner M (2009) New molecular insights into the mechanisms of cholestasis. J Hepatol 51:565\u2013580","journal-title":"J Hepatol"},{"key":"2437_CR166","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3748\/wjg.14.193","volume":"14","author":"Y Wei","year":"2008","unstructured":"Wei Y, Rector RS, Thyfault JP et al (2008) Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 14:193\u2013199","journal-title":"World J Gastroenterol"},{"key":"2437_CR167","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","volume":"18","author":"BL Woolbright","year":"2012","unstructured":"Woolbright BL, Jaeschke H (2012) Novel insight into mechanisms of cholestatic liver injury. World J Gastroenterol 18:4985\u20134993","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"2437_CR168","first-page":"170","volume":"3","author":"BL Woolbright","year":"2017","unstructured":"Woolbright BL, Jaeschke H (2017) The impact of sterile inflammation in acute liver injury. J Clin Transl Res 3(Suppl 1):170\u2013188","journal-title":"J Clin Transl Res"},{"key":"2437_CR169","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.taap.2013.09.023","volume":"273","author":"BL Woolbright","year":"2013","unstructured":"Woolbright BL, Antoine DJ, Jenkins RE et al (2013) Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice. Toxicol Appl Pharmacol 273:524\u2013531","journal-title":"Toxicol Appl Pharmacol"},{"key":"2437_CR170","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.toxlet.2014.04.001","volume":"228","author":"BL Woolbright","year":"2014","unstructured":"Woolbright BL, Li F, Xie Y et al (2014) Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice. Toxicol Lett 228:56\u201366","journal-title":"Toxicol Lett"},{"key":"2437_CR171","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","volume":"283","author":"BL Woolbright","year":"2015","unstructured":"Woolbright BL, Dorko K, Antoine DJ et al (2015) Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis. Toxicol Appl Pharmacol 283:168\u2013177","journal-title":"Toxicol Appl Pharmacol"},{"key":"2437_CR172","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/bcpt.12449","volume":"118","author":"BL Woolbright","year":"2016","unstructured":"Woolbright BL, McGill MR, Yan H et al (2016) Bile acid-induced toxicity in HepaRG cells recapitulates the response in primary human hepatocytes. Basic Clin Pharmacol Toxicol 118:160\u2013167","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2437_CR173","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/jps.23584","volume":"102","author":"K Yang","year":"2013","unstructured":"Yang K, K\u00f6ck K, Sedykh A et al (2013) An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. J Pharm Sci 102:3037\u20133057","journal-title":"J Pharm Sci"},{"key":"2437_CR174","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.xphs.2015.11.008","volume":"105","author":"K Yang","year":"2016","unstructured":"Yang K, Guo C, Woodhead JL et al (2016) Sandwich-cultured hepatocytes as a tool to study drug disposition and drug-induced liver injury. J Pharm Sci 105:443\u2013459","journal-title":"J Pharm Sci"},{"key":"2437_CR175","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.prp.2016.05.001","volume":"212","author":"X Yao","year":"2016","unstructured":"Yao X, Li Y, Cheng X et al (2016) ER stress contributes to alpha-naphthyl isothiocyanate-induced liver injury with cholestasis in mice. Pathol Res Pract 212:560\u2013567","journal-title":"Pathol Res Pract"},{"key":"2437_CR176","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1042\/bj3540591","volume":"354","author":"S Yasumiba","year":"2001","unstructured":"Yasumiba S, Tazuma S, Ochi H et al (2001) Cyclosporin A reduces canalicular membrane fluidity and regulates transporter function in rats. Biochem J 354:591\u2013596","journal-title":"Biochem J"},{"key":"2437_CR177","doi-asserted-by":"publisher","first-page":"34074","DOI":"10.1074\/jbc.M114.588616","volume":"289","author":"T Yu","year":"2014","unstructured":"Yu T, Wang L, Lee H et al (2014) Decreasing mitochondrial fission prevents cholestatic liver injury. J Biol Chem 289:34074\u201334088","journal-title":"J Biol Chem"},{"key":"2437_CR178","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1177\/1535370216657448","volume":"241","author":"K Zeilinger","year":"2016","unstructured":"Zeilinger K, Freyer N, Damm G et al (2016) Cell sources for in vitro human liver cell culture models. Exp Biol Med (Maywood) 241:1684\u20131698","journal-title":"Exp Biol Med (Maywood)"},{"key":"2437_CR179","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1478-3231.2011.02662.x","volume":"32","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Hong JY, Rockwell CE et al (2012) Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int 32:58\u201369","journal-title":"Liver Int"},{"key":"2437_CR180","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.tips.2017.12.002","volume":"39","author":"F Zhu","year":"2018","unstructured":"Zhu F, Li XX, Yang SY et al (2018) Clinical success of drug targets prospectively predicted by in silico study. Trends Pharmacol Sci 39:229\u2013231","journal-title":"Trends Pharmacol Sci"},{"key":"2437_CR181","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10354-006-0312-7","volume":"156","author":"G Zollner","year":"2006","unstructured":"Zollner G, Trauner M (2006) Molecular mechanisms of cholestasis. Wien Med Wochenschr 156:380\u2013385","journal-title":"Wien Med Wochenschr"},{"key":"2437_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2007.11.010","volume":"12","author":"G Zollner","year":"2008","unstructured":"Zollner G, Trauner M (2008) Mechanisms of cholestasis. Clin Liver Dis 12:1\u201326","journal-title":"Clin Liver Dis"},{"key":"2437_CR183","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1021\/mp060010s","volume":"3","author":"G Zollner","year":"2006","unstructured":"Zollner G, Marschall HU, Wagner M et al (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3:231\u2013251","journal-title":"Mol Pharm"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-019-02437-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T01:08:01Z","timestamp":1607216881000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-019-02437-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":183,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2437"],"URL":"https:\/\/doi.org\/10.1007\/s00204-019-02437-2","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,10]]},"assertion":[{"value":"26 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}